Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 2003 Feb 1;369(Pt 3):635–642. doi: 10.1042/BJ20020889

Group D prothrombin activators from snake venom are structural homologues of mammalian blood coagulation factor Xa.

Veena S Rao 1, Jeremiah S Joseph 1, R Manjunatha Kini 1
PMCID: PMC1223123  PMID: 12403650

Abstract

Procoagulant venoms of several Australian elapids contain proteinases that specifically activate prothrombin; among these, Group D activators are functionally similar to coagulation factor Xa (FXa). Structural information on this class of prothrombin activators will contribute significantly towards understanding the mechanism of FXa-mediated prothrombin activation. Here we present the purification of Group D prothrombin activators from three Australian snake venoms (Hoplocephalus stephensi, Notechis scutatus scutatus and Notechis ater niger) using a single-step method, and their N-terminal sequences. The N-terminal sequence of the heavy chain of hopsarin D (H. stephensi) revealed that a fully conserved Cys-7 was substituted with a Ser residue. We therefore determined the complete amino acid sequence of hopsarin D. Hopsarin D shows approximately 70% similarity with FXa and approximately 98% similarity with trocarin D, a Group D prothrombin activator from Tropidechis carinatus. It possesses the characteristic Gla domain, two epidermal growth factor-like domains and a serine proteinase domain. All residues important for catalysis are conserved, as are most regions involved in interactions with factor Va and prothrombin. However, there are some structural differences. Unlike FXa, hopsarin D is glycosylated in both its chains: in light-chain residue 52 and heavy-chain residue 45. The glycosylation on the heavy chain is a large carbohydrate moiety adjacent to the active-site pocket. Overall, hopsarin D is structurally and functionally similar to mammalian coagulation FXa.

Full Text

The Full Text of this article is available as a PDF (319.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bernard B. A., Newton S. A., Olden K. Effect of size and location of the oligosaccharide chain on protease degradation of bovine pancreatic ribonuclease. J Biol Chem. 1983 Oct 25;258(20):12198–12202. [PubMed] [Google Scholar]
  2. Bjoern S., Foster D. C., Thim L., Wiberg F. C., Christensen M., Komiyama Y., Pedersen A. H., Kisiel W. Human plasma and recombinant factor VII. Characterization of O-glycosylations at serine residues 52 and 60 and effects of site-directed mutagenesis of serine 52 to alanine. J Biol Chem. 1991 Jun 15;266(17):11051–11057. [PubMed] [Google Scholar]
  3. Fernlund P., Stenflo J. Beta-hydroxyaspartic acid in vitamin K-dependent proteins. J Biol Chem. 1983 Oct 25;258(20):12509–12512. [PubMed] [Google Scholar]
  4. Fujikawa K., Titani K., Davie E. W. Activation of bovine factor X (Stuart factor): conversion of factor Xaalpha to factor Xabeta. Proc Natl Acad Sci U S A. 1975 Sep;72(9):3359–3363. doi: 10.1073/pnas.72.9.3359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hase S., Kawabata S., Nishimura H., Takeya H., Sueyoshi T., Miyata T., Iwanaga S., Takao T., Shimonishi Y., Ikenaka T. A new trisaccharide sugar chain linked to a serine residue in bovine blood coagulation factors VII and IX. J Biochem. 1988 Dec;104(6):867–868. doi: 10.1093/oxfordjournals.jbchem.a122571. [DOI] [PubMed] [Google Scholar]
  6. Hertzberg M. S., Ben-Tal O., Furie B., Furie B. C. Construction, expression, and characterization of a chimera of factor IX and factor X. The role of the second epidermal growth factor domain and serine protease domain in factor Va binding. J Biol Chem. 1992 Jul 25;267(21):14759–14766. [PubMed] [Google Scholar]
  7. Huber P., Schmitz T., Griffin J., Jacobs M., Walsh C., Furie B., Furie B. C. Identification of amino acids in the gamma-carboxylation recognition site on the propeptide of prothrombin. J Biol Chem. 1990 Jul 25;265(21):12467–12473. [PubMed] [Google Scholar]
  8. Iino M., Foster D. C., Kisiel W. Functional consequences of mutations in Ser-52 and Ser-60 in human blood coagulation factor VII. Arch Biochem Biophys. 1998 Apr 15;352(2):182–192. doi: 10.1006/abbi.1998.0595. [DOI] [PubMed] [Google Scholar]
  9. Inglis A. S. Cleavage at aspartic acid. Methods Enzymol. 1983;91:324–332. doi: 10.1016/s0076-6879(83)91030-3. [DOI] [PubMed] [Google Scholar]
  10. Inoue K., Morita T. Identification of O-linked oligosaccharide chains in the activation peptides of blood coagulation factor X. The role of the carbohydrate moieties in the activation of factor X. Eur J Biochem. 1993 Nov 15;218(1):153–163. doi: 10.1111/j.1432-1033.1993.tb18361.x. [DOI] [PubMed] [Google Scholar]
  11. Iwanaga S., Nishimura H., Kawabata S., Kisiel W., Hase S., Ikenaka T. A new trisaccharide sugar chain linked to a serine residue in the first EGF-like domain of clotting factors VII and IX and protein Z. Adv Exp Med Biol. 1990;281:121–131. doi: 10.1007/978-1-4615-3806-6_12. [DOI] [PubMed] [Google Scholar]
  12. Joseph J. S., Chung M. C., Jeyaseelan K., Kini R. M. Amino acid sequence of trocarin, a prothrombin activator from Tropidechis carinatus venom: its structural similarity to coagulation factor Xa. Blood. 1999 Jul 15;94(2):621–631. [PubMed] [Google Scholar]
  13. Knobloch J. E., Suttie J. W. Vitamin K-dependent carboxylase. Control of enzyme activity by the "propeptide" region of factor X. J Biol Chem. 1987 Nov 15;262(32):15334–15337. [PubMed] [Google Scholar]
  14. Kobata A. Structures and functions of the sugar chains of glycoproteins. Eur J Biochem. 1992 Oct 15;209(2):483–501. doi: 10.1111/j.1432-1033.1992.tb17313.x. [DOI] [PubMed] [Google Scholar]
  15. Manjunatha Kini R., Morita T., Rosing J., Registry of Exogenous Hemostatic Factors of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis Classification and nomenclature of prothrombin activators isolated from snake venoms. Thromb Haemost. 2001 Aug;86(2):710–711. [PubMed] [Google Scholar]
  16. Mann K. G., Krishnaswamy S., Lawson J. H. Surface-dependent hemostasis. Semin Hematol. 1992 Jul;29(3):213–226. [PubMed] [Google Scholar]
  17. Marshall L. R., Herrmann R. P. Coagulant and anticoagulant actions of Australian snake venoms. Thromb Haemost. 1983 Oct 31;50(3):707–711. [PubMed] [Google Scholar]
  18. McDonald J. F., Shah A. M., Schwalbe R. A., Kisiel W., Dahlbäck B., Nelsestuen G. L. Comparison of naturally occurring vitamin K-dependent proteins: correlation of amino acid sequences and membrane binding properties suggests a membrane contact site. Biochemistry. 1997 Apr 29;36(17):5120–5127. doi: 10.1021/bi9626160. [DOI] [PubMed] [Google Scholar]
  19. McMullen B. A., Fujikawa K., Kisiel W., Sasagawa T., Howald W. N., Kwa E. Y., Weinstein B. Complete amino acid sequence of the light chain of human blood coagulation factor X: evidence for identification of residue 63 as beta-hydroxyaspartic acid. Biochemistry. 1983 Jun 7;22(12):2875–2884. doi: 10.1021/bi00281a016. [DOI] [PubMed] [Google Scholar]
  20. Nishimura H., Kawabata S., Kisiel W., Hase S., Ikenaka T., Takao T., Shimonishi Y., Iwanaga S. Identification of a disaccharide (Xyl-Glc) and a trisaccharide (Xyl2-Glc) O-glycosidically linked to a serine residue in the first epidermal growth factor-like domain of human factors VII and IX and protein Z and bovine protein Z. J Biol Chem. 1989 Dec 5;264(34):20320–20325. [PubMed] [Google Scholar]
  21. Pan L. C., Price P. A. The propeptide of rat bone gamma-carboxyglutamic acid protein shares homology with other vitamin K-dependent protein precursors. Proc Natl Acad Sci U S A. 1985 Sep;82(18):6109–6113. doi: 10.1073/pnas.82.18.6109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Poser J. W., Price P. A. A method for decarboxylation of gamma-carboxyglutamic acid in proteins. Properties of the decarboxylated gamma-carboxyglutamic acid protein from calf bone. J Biol Chem. 1979 Jan 25;254(2):431–436. [PubMed] [Google Scholar]
  23. Rosing J., Tans G., Govers-Riemslag J. W., Zwaal R. F., Hemker H. C. The role of phospholipids and factor Va in the prothrombinase complex. J Biol Chem. 1980 Jan 10;255(1):274–283. [PubMed] [Google Scholar]
  24. Rosing J., Tans G. Structural and functional properties of snake venom prothrombin activators. Toxicon. 1992 Dec;30(12):1515–1527. doi: 10.1016/0041-0101(92)90023-x. [DOI] [PubMed] [Google Scholar]
  25. Rudd P. M., Joao H. C., Coghill E., Fiten P., Saunders M. R., Opdenakker G., Dwek R. A. Glycoforms modify the dynamic stability and functional activity of an enzyme. Biochemistry. 1994 Jan 11;33(1):17–22. doi: 10.1021/bi00167a003. [DOI] [PubMed] [Google Scholar]
  26. Sinha U., Wolf D. L. Carbohydrate residues modulate the activation of coagulation factor X. J Biol Chem. 1993 Feb 15;268(5):3048–3051. [PubMed] [Google Scholar]
  27. Speijer H., Govers-Riemslag J. W., Zwaal R. F., Rosing J. Prothrombin activation by an activator from the venom of Oxyuranus scutellatus (Taipan snake). J Biol Chem. 1986 Oct 5;261(28):13258–13267. [PubMed] [Google Scholar]
  28. Stenflo J., Lundwall A., Dahlbäck B. beta-Hydroxyasparagine in domains homologous to the epidermal growth factor precursor in vitamin K-dependent protein S. Proc Natl Acad Sci U S A. 1987 Jan;84(2):368–372. doi: 10.1073/pnas.84.2.368. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Suzuki H., Harada A., Hayashi Y., Wada K., Asaka J., Gotoh B., Ogasawara T., Nagai Y. Primary structure of the virus activating protease from chick embryo. Its identity with the blood clotting factor Xa. FEBS Lett. 1991 Jun 3;283(2):281–285. doi: 10.1016/0014-5793(91)80608-6. [DOI] [PubMed] [Google Scholar]
  30. Tans G., Govers-Riemslag J. W., van Rijn J. L., Rosing J. Purification and properties of a prothrombin activator from the venom of Notechis scutatus scutatus. J Biol Chem. 1985 Aug 5;260(16):9366–9372. [PubMed] [Google Scholar]
  31. Ulrich M. M., Furie B., Jacobs M. R., Vermeer C., Furie B. C. Vitamin K-dependent carboxylation. A synthetic peptide based upon the gamma-carboxylation recognition site sequence of the prothrombin propeptide is an active substrate for the carboxylase in vitro. J Biol Chem. 1988 Jul 15;263(20):9697–9702. [PubMed] [Google Scholar]
  32. Walsh M. T., Watzlawick H., Putnam F. W., Schmid K., Brossmer R. Effect of the carbohydrate moiety on the secondary structure of beta 2-glycoprotein. I. Implications for the biosynthesis and folding of glycoproteins. Biochemistry. 1990 Jul 3;29(26):6250–6257. doi: 10.1021/bi00478a020. [DOI] [PubMed] [Google Scholar]
  33. Wang C., Eufemi M., Turano C., Giartosio A. Influence of the carbohydrate moiety on the stability of glycoproteins. Biochemistry. 1996 Jun 11;35(23):7299–7307. doi: 10.1021/bi9517704. [DOI] [PubMed] [Google Scholar]
  34. Williams V., White J. Purification and properties of a procoagulant from peninsula tiger snake (Notechis ater niger) venom. Toxicon. 1989;27(7):773–779. doi: 10.1016/0041-0101(89)90044-5. [DOI] [PubMed] [Google Scholar]
  35. van Rijn J. L., Govers-Riemslag J. W., Zwaal R. F., Rosing J. Kinetic studies of prothrombin activation: effect of factor Va and phospholipids on the formation of the enzyme-substrate complex. Biochemistry. 1984 Sep 25;23(20):4557–4564. doi: 10.1021/bi00315a008. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES